Spire Wealth Management Immuno Gen, Inc. Transaction History

Spire Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$12.46 - $29.95 $249 - $599	20 New	20 $0
Q1 2022 Apr 18, 2022	SELL	$4.26 - $7.48 $643 - $1,129	-151 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$4.75 - $7.5 $717 - $1,132	151 New	151 $1,000
Q2 2021 Jul 26, 2021	SELL	$5.79 - $8.6 $4,070 - $6,045	-703 Closed	0 $0
Q1 2021 May 21, 2021	BUY	$6.5 - $10.53 $4,017 - $6,507	618 Added 727.06%	703 $6,000
Q1 2021 May 07, 2021	BUY	$6.5 - $10.53 $552 - $895	85 New	85 $1,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.